ALVR
AlloVir Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website allovir.com
- Employees(FY) 114
- ISIN US0198181036
Performance
-5.02%
1W
+5.51%
1M
+10.77%
3M
-53.01%
6M
+14.06%
YTD
-81.32%
1Y
Profile
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was incorporated in 2013 and is based in Waltham, Massachusetts.
Technical Analysis of ALVR 2024-05-10
Overview:
In analyzing the technical indicators for ALVR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations for potential...
Recent News & Updates
- 2024-05-13 20:53
ALVR Stock Earnings: AlloVir Misses EPS for Q1 2024(Investorplace)
- 2024-03-18 03:53
ALVR Stock Earnings: AlloVir Misses EPS for Q4 2023(Investorplace)
- 2024-03-12 23:53
- 2024-03-12 22:00
- 2024-03-11 17:50
- 2024-03-06 05:17
- 2024-03-04 04:37
- 2024-02-27 12:06
- 2024-02-26 19:00
- 2024-02-25 23:27
- 2024-02-22 21:30
- 2024-01-28 20:40
- 2024-01-23 20:45
- 2024-01-11 20:35
- 2024-01-04 22:03
- 2024-01-04 19:37
- 2023-12-25 21:04
- 2023-12-21 20:31
- 2023-12-21 19:30
- 2023-12-21 18:10
- 2023-12-21 18:00
- 2023-12-04 19:55
- 2023-11-15 18:00
- 2023-11-01 22:04
AlloVir Inc (ALVR) Reports Q3 2023 Financial Results(Yahoo Finance)
- 2023-11-01 19:00
AlloVir Reports Third Quarter 2023 Financial Results(Businesswire)
- 2023-09-21 02:44
Why AlloVir Stock Dropped Today(Yahoo Finance)
- 2023-09-13 21:59
- 2023-08-27 19:00
AlloVir to Present at Upcoming Investor Conferences(Yahoo Finance)
- 2023-08-02 19:00
AlloVir Reports Second Quarter 2023 Financial Results(Yahoo Finance)
- 2023-07-20 19:17
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%(Yahoo Finance)
Page 1 of 4
previousnext